The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up: Long-term ustekinumab safety in psoriasis
Abstract
BACKGROUND: Long-term safety evaluations of biologics are needed to inform patient management decisions. OBJECTIVES: To evaluate the safety of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years. METHODS: Safety data were pooled from four studies of ustekinumab for psoriasis. Rates of adverse events (AEs), serious AEs (SAEs) and AEs of interest [infections, nonmelanoma skin cancers (NMSCs), other malignancies and major adverse cardiovascular events (MACE)] per 100 patient-years (PY) of follow-up were analysed by ustekinumab dose (45 or 90 mg) and by year of follow-up (years 1-5) to evaluate the dose response and impact of cumulative exposure. Observed rates of overall mortality and other malignancies were compared with those expected in the general U.S. population. RESULTS: Analyses included 3117 patients (8998 PY) who received one or more doses of ustekinumab, with 1482 patients treated for ≥4 years (including 838 patients ≥5 years). At year 5, event rates (45 mg, 90 mg, respectively) for overall AEs (242·6, 225·3), SAEs (7·0, 7·2), serious infections (0·98, 1·19), NMSCs (0·64, 0·44), other malignancies (0·59, 0·61) and MACE (0·56, 0·36) were comparable between dose groups. Year-to-year variability was observed, but no increasing trend was evident. Rates of overall mortality and other malignancies were comparable with those expected in the general U.S. population. CONCLUSIONS: No dose-related or cumulative toxicity was observed with increasing duration of ustekinumab exposure for up to 5 years. Rates of AEs reported in ustekinumab psoriasis trials are generally comparable with those reported for other biologics approved for the treatment of moderate-to-severe psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Self-citationSpectrum of cancer risk among US solid organ transplant recipients
Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., et al. (2011) · JAMA · doi:10.1001/jama.2011.1592 · Cited by 1,524
Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
Self-citationEtanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018
The IL-12 Family of Heterodimeric Cytokines
Trinchieri, G., Pflanz, S., & Kastelein, R. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00296-6 · Cited by 922
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Griffiths, C. E. M., Strober, B. E., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C., Xia, Y., Zhou, B., Li, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0810652 · Cited by 859
Self-citationA Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Self-citationRubin, A. I., Chen, E. H., & Ratner, D. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044151 · Cited by 769
Mehta, N. N., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp567 · Cited by 706
Burmester, G. R., Panaccione, R., Gordon, K. B., McIlraith, M. J., & Lacerda, A. P. M. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201244 · Cited by 591
Self-citationGottlieb, A. B., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Baker, D., Bala, M., Marano, C. W., & Menter, A. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.021 · Cited by 581
Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
Micha, R., Imamura, F., Wyler von Ballmoos, M., Solomon, D. H., Hernán, M. A., Ridker, P. M., & Mozaffarian, D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.054 · Cited by 535
Gordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.027 · Cited by 510
Self-citationInborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features
Filipe-Santos, O., Bustamante, J., Chapgier, A., Vogt, G., de Beaucoudrey, L., Feinberg, J., Jouanguy, E., Boisson-Dupuis, S., Fieschi, C., Picard, C., et al. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.010 · Cited by 464
Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., & Edwards, C. J. (2010) · Rheumatology · doi:10.1093/rheumatology/kep366 · Cited by 357
Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events
Mehta, N. N., Yu, Y., Pinnelas, R., Krishnamoorthy, P., Shin, D. B., Troxel, A. B., & Gelfand, J. M. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.03.028 · Cited by 345
Archier, E., Devaux, S., Castela, E., Gallini, A., Aubin, F., Le Maître, M., Aractingi, S., Bachelez, H., Cribier, B., Joly, P., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04520.x · Cited by 311
Skin cancer in solid organ transplant recipients: Advances in therapy and management
O’Reilly Zwald, F., & Brown, M. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.062 · Cited by 311
Wu, J. J., Poon, K.-Y. T., Channual, J. C., & Shen, A. Y.-J. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.2502 · Cited by 304
Ryan, C., Leonardi, C. L., Krueger, J. G., Kimball, A. B., Strober, B. E., Gordon, K. B., Langley, R. G., de Lemos, J. A., Daoud, Y., Blankenship, D., et al. (2011) · JAMA · doi:10.1001/jama.2011.1211 · Cited by 289
Self-citationPsoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study
Ahlehoff, O., Gislason, G. H., Jørgensen, C. H., Lindhardsen, J., Charlot, M., Olesen, J. B., Abildstrøm, S. Z., Skov, L., Torp-Pedersen, C., & Hansen, P. R. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr285 · Cited by 246
Treatments for psoriasis and the risk of malignancy
Patel, R. V., Clark, L. N., Lebwohl, M., & Weinberg, J. M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.12.031 · Cited by 235
Self-citationKagami, S., Rizzo, H. L., Kurtz, S. E., Miller, L. S., & Blauvelt, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001153 · Cited by 216
Kimball, A. B., Papp, K. A., Wasfi, Y., Chan, D., Bissonnette, R., Sofen, H., Yeilding, N., Li, S., Szapary, P., Gordon, K. B., et al. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12046 · Cited by 213
Self-citationWestlake, S. L., Colebatch, A. N., Baird, J., Curzen, N., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., & Edwards, C. J. (2011) · Rheumatology · doi:10.1093/rheumatology/keq316 · Cited by 213
Naldi, L., & Griffiths, C. E. M. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06563.x · Cited by 183
Self-citationTzellos, T., Kyrgidis, A., & Zouboulis, C. C. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04500.x · Cited by 173
Mini‐review The role of interleukin‐12 in human infectious diseases: only a faint signature
Fieschi, C., & Casanova, J. (2003) · European Journal of Immunology · doi:10.1002/eji.200324038 · Cited by 167
Gordon, K. B., Papp, K. A., Langley, R. G. B., HO, V. C., Kimball, A. B., Guzzo, C. A., Yeilding, N. M., Szapary, P. O., Fakharzadeh, S. S., Li, S., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.06.041 · Cited by 142
Self-citationReich, K., Langley, R. G. B., Lebwohl, M., Szapary, P. O., Guzzo, C. A., Yeilding, N. M., Li, S., Hsu, M.-C., & Griffiths, C. E. M. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10257.x · Cited by 137
Self-citationKimball, A. B., Szapary, P. O., Mrowietz, U., Reich, K., Langley, R. G. B., You, Y., Hsu, M.-C., Yeilding, N. M., Rader, D. J., & Mehta, N. N. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.06.035 · Cited by 136
Self-citationThe effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study
Abuabara, K., Lee, H., & Kimball, A. B. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10525.x · Cited by 128
Burden, A. D., Warren, R. B., Kleyn, C. E., McElhone, K., Smith, C. H., Reynolds, N. J., Ormerod, A. D., Griffiths, C. E. M., & on behalf of the BADBIR Study Group (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10835.x · Cited by 128
Self-citationPsoriasis and Risk of Incident Cancer: An Inception Cohort Study with a Nested Case–Control Analysis
Brauchli, Y. B., Jick, S. S., Miret, M., & Meier, C. R. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.113 · Cited by 128
Wakkee, M., de Vries, E., van den Haak, P., & Nijsten, T. E. C. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.08.036 · Cited by 114
Lebwohl, M., Leonardi, C. L., Griffiths, C. E. M., Prinz, J. C., Szapary, P. O., Yeilding, N. M., Guzzo, C. A., Li, S., Hsu, M.-C., & Strober, B. E. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.06.011 · Cited by 108
Self-citationPapp, K. A., Poulin, Y. P., Bissonnette, R., Bourcier, M., Toth, D. P., Rosoph, L., Poulin-Costello, M., Setterfield, M., & Syrotuik, J. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.07.026 · Cited by 100
Self-citationPsoriasis and Vascular Disease—Risk Factors and Outcomes: A Systematic Review of the Literature
Patel, R. V., Shelling, M. L., Prodanovich, S., Federman, D. G., & Kirsner, R. S. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1698-5 · Cited by 88
Papp, K. A., Strober, B. E., Augustin, M., Calabro, S., Londhe, A., & Chevrier, M. R. (2012) · PubMed · Cited by 84
Self-citationPariser, D. M., Leonardi, C. L., Gordon, K. B., Gottlieb, A. B., Tyring, S. K., Papp, K. A., Li, J., & Baumgartner, S. W. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.07.040 · Cited by 81
Self-citationValidation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies
Geng, D., Shankar, G., Schantz, A., Rajadhyaksha, M., Davis, H. M., & Wagner, C. L. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.04.045 · Cited by 71
Cutaneous Melanoma In Situ: Translational Evidence from a Large Population-Based Study
D, S. M. M., & Nitti, D. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0340 · Cited by 69
Krathen, M., Gottlieb, A. B., & Mease, P. J. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100041 · Cited by 67
Tsai, T., Chiu, H., Song, M. W., & Chan, D. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11162.x · Cited by 54
Self-citationvan de Vosse, E., & Ottenhoff, T. H. M. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.10.032 · Cited by 51
Abuabara, K., Wan, J., Troxel, A. B., Shin, D. B., Voorhees, A. S. V., Bebo, B. F., Krueger, G. G., Duffin, K. C., & Gelfand, J. M. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.07.007 · Cited by 26
Safety of Conventional Systemic Agents and Biologic Agents in the Treatment of Psoriasis
Bissonnette, R., HO, V. C., & Langley, R. G. B. (2009) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2009.00023 · Cited by 17
Self-citation
Cited by
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R., Blank, M. A., Johanns, J., Gao, L.-L., Miao, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602773 · Cited by 1,845
Greb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M. G., Gladman, D. D., Wu, J. J., Mehta, N. N., Finlay, A. Y., & Gottlieb, A. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.82 · Cited by 922
Self-citationTeng, M. W. L., Bowman, E. P., McElwee, J. J., Smyth, M. J., Casanova, J.-L., Cooper, A. M., & Cua, D. J. (2015) · Nature Medicine · doi:10.1038/nm.3895 · Cited by 873
Ritchlin, C., Rahman, P., Kavanaugh, A., McInnes, I. B., Puig, L., Li, S., Wang, Y., Shen, Y.-K., Doyle, M. K., Mendelsohn, A. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204655 · Cited by 662
Self-citation
Metadata
- Authors
- Papp, K. A., Griffiths, C. E. M., Gordon, K., Lebwohl, M., Szapary, P. O., Wasfi, Y., Chan, D., Hsu, M.-C., Ho, V., Ghislain, P. D., Strober, B., Reich, K., & on behalf of the PHOENIX 1, P. 2. A. A. I.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-25
- Volume
- 168
- Issue
- 4
- Pages
- 844-854
- ISSN
- 0007-0963 (ISSN-L)
- OpenAlex
- W1661616496
- Cited by
- 415
- References
- 50
- FWCI
- 21.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.